Rosuvastatin protects against coronary microembolization-induced cardiac injury via inhibiting NLRP3 inflammasome activation

Coronary microembolization (CME), a common reason for periprocedural myocardial infarction (PMI), bears very important prognostic implications. However, the molecular mechanisms related to CME remain largely elusive. Statins have been shown to prevent PMI, but the underlying mechanism has not been i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Ao, Chen, Zhangwei, Zhou, You, Wu, Yuan, Xia, Yan, Lu, Danbo, Fan, Mengkang, Li, Su, Chen, Jinxiang, Sun, Aijun, Zou, Yunzeng, Qian, Juying, Ge, Junbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804109/
https://www.ncbi.nlm.nih.gov/pubmed/33436548
http://dx.doi.org/10.1038/s41419-021-03389-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804109/
https://www.ncbi.nlm.nih.gov/pubmed/33436548
http://dx.doi.org/10.1038/s41419-021-03389-1

Ejemplares similares